Loading...

AI Diagnostics Partnerships And Healthcare Demand Will Support Global Expansion Ahead

Published
07 Nov 24
Updated
28 Oct 25
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-17.1%
7D
-10.9%

Author's Valuation

€58.8126.4% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on 28 Oct 25

Narrative Update on Siemens Healthineers The consensus analyst price target for Siemens Healthineers was recently lowered by EUR 1 to EUR 61. Analysts are incorporating minor adjustments to growth and profitability expectations in their updated outlook.

Shared on 14 Oct 25

Fair value Decreased 2.29%

Advanced Imaging And AI Diagnostics Will Expand Global Markets

Analysts have slightly lowered their price target for Siemens Healthineers, reducing it from €62 to €61. They cited modest adjustments to growth and margin forecasts in their latest assessment.

Shared on 01 May 25

Fair value Decreased 4.43%

Advanced Imaging And AI Diagnostics Will Expand Global Markets

Shared on 23 Apr 25

Fair value Increased 5.38%

Photon-counting CT And AI Advancements Will Sustain Future Competitiveness

AnalystConsensusTarget has decreased shares outstanding growth rate from 0.0% to 0.0%.

Shared on 17 Apr 25

Fair value Decreased 6.06%

Photon-counting CT And AI Advancements Will Sustain Future Competitiveness

Shared on 09 Apr 25

Fair value Decreased 0.17%

Photon-counting CT And AI Advancements Will Sustain Future Competitiveness

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 02 Apr 25

Fair value Increased 2.08%

Photon-counting CT And AI Advancements Will Sustain Future Competitiveness

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 26 Mar 25

Photon-counting CT And AI Advancements Will Sustain Future Competitiveness

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 19 Mar 25

Fair value Increased 1.02%

Photon-counting CT And AI Advancements Will Sustain Future Competitiveness

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 12 Mar 25

Fair value Increased 2.42%

Photon-counting CT And AI Advancements Will Sustain Future Competitiveness

AnalystConsensusTarget made no meaningful changes to valuation assumptions.